Background: Comparative outcomes of HBV-infected compensated cirrhosis with low-level
viremia (LLV) versus maintained virological response (MVR) are unclear. We conducted a …

Chronic hepatitis B virus (HBV) infection, which ultimately leads to liver cirrhosis, hepatic
decompensation, and hepatocellular carcinoma (HCC), remains a significant disease …

Chronic hepatitis B (CHB) is a major cause of chronic liver diseases in Korea and remains a
threat to public health due to its high morbidity and disease-related mortality. Since the latest …

Introduction The clinical significance of persistent positive in Hepatitis B Virus (HBV) DNA
level in patients receiving antiviral therapy is not well known. We investigated factors …

METHODS: Six hundred twenty-seven untreated patients with chronic hepatitis B with
compensated cirrhosis were analyzed retrospectively. The risk of hepatocellular carcinoma …

Background Due to stringent reimbursement criteria, significant numbers of patients with
compensated cirrhosis (CC) and low-level viremia [LLV; serum hepatitis B virus (HBV)–DNA …

BACKGROUND Whether patients with compensated cirrhosis and low-level viremia (LLV) of
hepatitis B should receive antiviral therapy (AVT) is still controversial, and published results …

Chronic hepatitis B (CHB) is a major cause of chronic liver diseases in Korea and remains a
threat to public health due to its high morbidity and disease-related mortality. Since the latest …

Methods: We conducted a retrospective cohort study that enrolled 16,895 CHB patients from
January 2008 to December 2020. The patients were divided into three groups for …

Patients with hepatitis B virus-related cirrhosis and low-level viremia represent a special
group that might benefit from treatment because of their higher risk of complications …